InVivo Therapeutics Holdings Corporation
InVivo Therapeutics Holdings Corporation（NVIV）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
nviv · 股价预测 · 3 位分析师（近3月）· FMP
分析师评级与共识
基于过去 3 个月内 3 位华尔街分析师
Buy
3 位分析师
共识
评级分布
12 个月目标价
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $0.32
短期股价预测
预测引擎就绪后将提供短期股价预测。
长期股价预测
预测引擎就绪后将提供长期股价预测。
基于技术分析的股价预测
预测引擎就绪后将提供技术分析。
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|
Wall Street analysts have recently issued updated ratings on InVivo Therapeutics Holdings Corporation (NVIV) stock. Of the recent 0 rating actions, 0 were upgrades and 0 were downgrades. 3 analysts currently cover NVIV.
分析师推荐趋势
NVIV analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 0 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
—
Revenue Next Year
—
EPS This Year
—
EPS Next Year
—
EPS ForecastReported vs Estimated
Analysts forecast NVIV EPS of $— for the current fiscal year, based on estimates from 0 analysts. The NVIV revenue forecast is — for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
NVIV 股价预测由两类独立数据源支撑：来自 3 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。NVIV 的共识目标价为 $0.00（+0.0% 上行空间），分析师共识为 Buy。
InVivo Therapeutics Holdings Corporation 在 NASDAQ 上市，代码 NVIV。NVIV 在 2027 年的整体展望偏积极，在覆盖分析师中约 100% 对应 Buy 共识。
常见问题
NVIV 预测 · 8 个问题根据 3 位华尔街分析师，NVIV 的 12 个月平均目标价为 $0.00，最高 $0.00、最低 $0.00。若有图表，中位目标价可在上方查看。相对当前价 $0.32，隐含约 +0.0% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.